We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radiofrequency Ablation System Treats Spinal Tumors

By HospiMedica International staff writers
Posted on 14 Oct 2013
A highly precise ablation system permits minimally invasive targeted tumor necrosis of metastatic spinal tumors.

The Spinal Tumor Ablation with Radiofrequency (STAR) system uses targeted radiofrequency ablation (t-RFA) to deliver energy that heats and destroys the metastatic spinal tumor, providing rapid and lasting pain relief in a single treatment. More...
The bipolar device provides the physician with real-time procedural information using temperature-measuring thermocouples that monitor and adjust, in real time, the RF energy being delivered to the tumor, maximizing tumor destruction while minimizing the risk of impacting healthy surrounding tissue.

During the procedure, the tumor is approached in a uniportal manner with a series of navigational osteotomes and the steerable ablation Instrument. Once positioned appropriately, the articulating electrode of the ablation Instrument is deployed, and RF energy is delivered from the generator directly into the tumor. Local temperatures in and around the ablation zone are continuously displayed and physician controlled at all times. When the required number of RF ablation cycles has been reached, the pedicle access may be closed.

Following ablation with the STAR system, the vertebrae are stabilized with ultra-high viscosity cement; the minimally invasive procedure generally takes about an hour. Unlike patients being treated with radiation therapy for metastatic spinal tumors, those who undergo RF ablation therapy for the same reasons may have no need to delay their systemic and primary cancer regimens. The STAR system is a product of DFine (San Jose, CA, USA), and has received the European community CE mark of approval.

“We are very excited to bring this new treatment modality to Europe so that the hundreds of thousands of patients suffering from painful spinal tumors can receive the rapid pain relief that patients here in the US have experienced. This represents a significant milestone for the company,” said Greg Barrett, CEO of DFine.

Metastatic spinal tumors are a growth of cell mass in or around the vertebra near the spinal cord. It is estimated that 30%–40% of cancer patients will likely develop metastatic spinal tumors. Currently, patients suffering from painful spinal tumors have limited options, and many live in excruciating pain, unable to perform activities of daily living.

Related Links:
DFine


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.